The cannabis-derived substance provides fewer side effects, with less potential for abuse.
The findings are a promising step for a disease with limited treatment options.
A new survey shows high usage rates of cannabinoids like CBD for multiple sclerosis, but most patients are figuring out these new products on their own.
“Secret shopper” study finds stigma is highest against those who say their last doctor stopped prescribing opioids to them.
Minority experience worsening of symptoms over time, especially younger people.
Study calls into question rush to use brain stimulation technology to treat Parkinson's and pain disorders.